human il2 elisa kit Search Results


human il 2 quantikine  (R&D Systems)
95
R&D Systems human il 2 quantikine
Human Il 2 Quantikine, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+Quantikine+ELISA+Kit/pm12428174-94-10-13
Average 95 stars, based on 1 article reviews
human il 2 quantikine - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
human crp elisa kit  (Diaclone)
93
Diaclone human crp elisa kit
Human Crp Elisa Kit, supplied by Diaclone, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+ELISA+Kit/ppr0616344-44-7-11
Average 93 stars, based on 1 article reviews
human crp elisa kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
high sensitivity hs elisa kits  (Diaclone)
93
Diaclone high sensitivity hs elisa kits
High Sensitivity Hs Elisa Kits, supplied by Diaclone, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+HS+ELISA+Kit/pmc09310294-163-14-18
Average 93 stars, based on 1 article reviews
high sensitivity hs elisa kits - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
quantiglo elisa kit  (R&D Systems)
94
R&D Systems quantiglo elisa kit
Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF <t>QuantiGlo</t> <t>ELISA)</t> were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.
Quantiglo Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+QuantiGlo+ELISA+Kit/pmc12340029-91-41-44
Average 94 stars, based on 1 article reviews
quantiglo elisa kit - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
il 2  (ABclonal Biotechnology)
94
ABclonal Biotechnology il 2
Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF <t>QuantiGlo</t> <t>ELISA)</t> were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.
Il 2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+ELISA+Kit/pmc11440895-124-17-20
Average 94 stars, based on 1 article reviews
il 2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
product information r d systems quantiglo il 2 immunoassay  (R&D Systems)
94
R&D Systems product information r d systems quantiglo il 2 immunoassay
Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF <t>QuantiGlo</t> <t>ELISA)</t> were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.
Product Information R D Systems Quantiglo Il 2 Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+QuantiGlo+ELISA+Kit/pmc03030995-205-136-138
Average 94 stars, based on 1 article reviews
product information r d systems quantiglo il 2 immunoassay - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
human il 2 quantikine elisa kit  (R&D Systems)
95
R&D Systems human il 2 quantikine elisa kit
Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF <t>QuantiGlo</t> <t>ELISA)</t> were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.
Human Il 2 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+Quantikine+ELISA+Kit/pmc08056350-43-6-35
Average 95 stars, based on 1 article reviews
human il 2 quantikine elisa kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
elisa kits  (Elabscience Biotechnology)
94
Elabscience Biotechnology elisa kits
Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF <t>QuantiGlo</t> <t>ELISA)</t> were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.
Elisa Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+(Interleukin+2)+ELISA+Kit/10__1016_slash_j__ijpx__2024__100311-105-2-5
Average 94 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
il2 elisa kits  (R&D Systems)
93
R&D Systems il2 elisa kits
Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF <t>QuantiGlo</t> <t>ELISA)</t> were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.
Il2 Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+ELISA+Kit+(Colorimetric)/pmc07925432-210-7-10
Average 93 stars, based on 1 article reviews
il2 elisa kits - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
human il 2 sandwich elisa kit  (Proteintech)
93
Proteintech human il 2 sandwich elisa kit
Interleukin-2 secretion, but not CD69 expression, is significantly reduced by Soq treatment. (A) Dotplot showing the percentage of CD69-positive cells measured by flow cytometry after 24 hours of soluble antibody stimulation. (B) Dotplot showing the concentration of IL-2 in the cell culture supernatant measured by <t>ELISA</t> after 24 hours of soluble antibody stimulation. (C-D) As in (A-B), except for APC-pMHC stimulation. (E-F) As in (A-B), except for Raji-co-culture stimulation of a second-generation CD19-CAR. Statistical analysis for flow cytometry and ELISA data was performed using a one-way ANOVA followed by the Holm-Sidak correction of Fisher’s LSD pairwise comparisons, if applicable, and is available in Supporting Tables 13-18.
Human Il 2 Sandwich Elisa Kit, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+ELISA+Kit/bio_rxiv__2025__11__03__686362-166-6-11
Average 93 stars, based on 1 article reviews
human il 2 sandwich elisa kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
enzyme linked immunosorbent assay kits  (R&D Systems)
92
R&D Systems enzyme linked immunosorbent assay kits
Interleukin-2 secretion, but not CD69 expression, is significantly reduced by Soq treatment. (A) Dotplot showing the percentage of CD69-positive cells measured by flow cytometry after 24 hours of soluble antibody stimulation. (B) Dotplot showing the concentration of IL-2 in the cell culture supernatant measured by <t>ELISA</t> after 24 hours of soluble antibody stimulation. (C-D) As in (A-B), except for APC-pMHC stimulation. (E-F) As in (A-B), except for Raji-co-culture stimulation of a second-generation CD19-CAR. Statistical analysis for flow cytometry and ELISA data was performed using a one-way ANOVA followed by the Holm-Sidak correction of Fisher’s LSD pairwise comparisons, if applicable, and is available in Supporting Tables 13-18.
Enzyme Linked Immunosorbent Assay Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+Quantikine+HS+ELISA+Kit/pm23969907-124-14-25
Average 92 stars, based on 1 article reviews
enzyme linked immunosorbent assay kits - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
quantikine hs human elisa kits  (R&D Systems)
94
R&D Systems quantikine hs human elisa kits
Interleukin-2 secretion, but not CD69 expression, is significantly reduced by Soq treatment. (A) Dotplot showing the percentage of CD69-positive cells measured by flow cytometry after 24 hours of soluble antibody stimulation. (B) Dotplot showing the concentration of IL-2 in the cell culture supernatant measured by <t>ELISA</t> after 24 hours of soluble antibody stimulation. (C-D) As in (A-B), except for APC-pMHC stimulation. (E-F) As in (A-B), except for Raji-co-culture stimulation of a second-generation CD19-CAR. Statistical analysis for flow cytometry and ELISA data was performed using a one-way ANOVA followed by the Holm-Sidak correction of Fisher’s LSD pairwise comparisons, if applicable, and is available in Supporting Tables 13-18.
Quantikine Hs Human Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il2+elisa+kit/Human+IL-2+Quantikine+HS+ELISA+Kit/pmc03857794-88-14-23
Average 94 stars, based on 1 article reviews
quantikine hs human elisa kits - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF QuantiGlo ELISA) were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.

Journal: Scientific Reports

Article Title: Validation of a potency assay for CD34 + cell based therapy

doi: 10.1038/s41598-025-14828-w

Figure Lengend Snippet: Quantification of VEGF in the supernatant of ProtheraCytes cultures as a potency assay. ( A ) ( C ) Concentration of VEGF in cell culture supernatants after 9 days of CD34 + cell expansion from four healthy donors and 16 AMI patients (Phase I/IIb clinical trial). ( B ) No significant difference observed when VEGF concentration was compared between AMI patients and healthy donors, but a significant difference was observed between AMI patients and StemFeed culture medium as negative control (t-test, p = 0.0021). ( D ) No significant difference (t-test, p = 0.0670) when VEGF concentrations in AMI patient and healthy donor supernatants quantified with the conventional method (Human VEGF QuantiGlo ELISA) were compared to those quantified with the ELLA system and its VEGF cartridge. These results have also been normalized to the number of CD34 + cells obtained after expansion and can be found in Supplemental Fig. 1.

Article Snippet: The development of the potency assay based on the quantification of VEGF secreted by CD34 + cells from AMI patients in cell culture supernatants collected after 9 days of cell expansion was initiated using the traditional ELISA luminescence method with the QuantiGlo ELISA Kit (R&D Systems) and its positive control .

Techniques: Potency Assay, Concentration Assay, Cell Culture, Negative Control, Enzyme-linked Immunosorbent Assay

Interleukin-2 secretion, but not CD69 expression, is significantly reduced by Soq treatment. (A) Dotplot showing the percentage of CD69-positive cells measured by flow cytometry after 24 hours of soluble antibody stimulation. (B) Dotplot showing the concentration of IL-2 in the cell culture supernatant measured by ELISA after 24 hours of soluble antibody stimulation. (C-D) As in (A-B), except for APC-pMHC stimulation. (E-F) As in (A-B), except for Raji-co-culture stimulation of a second-generation CD19-CAR. Statistical analysis for flow cytometry and ELISA data was performed using a one-way ANOVA followed by the Holm-Sidak correction of Fisher’s LSD pairwise comparisons, if applicable, and is available in Supporting Tables 13-18.

Journal: bioRxiv

Article Title: Phospotyrosine proteomics reveals novel Zap70 and Itk pathway targets downstream of TCR and CAR in Jurkat T cells

doi: 10.1101/2025.11.03.686362

Figure Lengend Snippet: Interleukin-2 secretion, but not CD69 expression, is significantly reduced by Soq treatment. (A) Dotplot showing the percentage of CD69-positive cells measured by flow cytometry after 24 hours of soluble antibody stimulation. (B) Dotplot showing the concentration of IL-2 in the cell culture supernatant measured by ELISA after 24 hours of soluble antibody stimulation. (C-D) As in (A-B), except for APC-pMHC stimulation. (E-F) As in (A-B), except for Raji-co-culture stimulation of a second-generation CD19-CAR. Statistical analysis for flow cytometry and ELISA data was performed using a one-way ANOVA followed by the Holm-Sidak correction of Fisher’s LSD pairwise comparisons, if applicable, and is available in Supporting Tables 13-18.

Article Snippet: Interleuken-2 abundance was assessed using the Human IL-2 Sandwich ELISA Kit (proteintech #KE00017) per the manufacturer’s instructions.

Techniques: Expressing, Flow Cytometry, Concentration Assay, Cell Culture, Enzyme-linked Immunosorbent Assay, Co-Culture Assay